-The Times of India Less than 24 hours before the Supreme Court takes up the coal scam hearing on Tuesday, a blame game broke out within the government over who was responsible for incorrectly telling the court that the CBI had not shared the contents of its status report on " Coalgate" with the political executive. In a four-page letter to attorney general Goolam Vahanvati, additional solicitor general Harin Raval said he...
More »SEARCH RESULT
Total Matching Records found : 5631
Coalgate: You don't need to take instructions from political masters, SC to CBI
-The Indian Express In a big embarrassment to the government in the Coalgate case, the Supreme Court today termed as 'very disturbing' the CBI affidavit on sharing its report with the Law Minister and others and slammed the agency for having kept the court in the dark on the issue. Hearing the coal blocks allocation scam case in a packed courtroom, the bench said 'suppression' of the fact that CBI has...
More »Strong medicine for poor countries-Nayanima Basu
-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...
More »Madhya Pradesh to recognize live-in relationships -Manjari Mishra
-The Times of India JABALPUR: Live-in relationships are set to get official sanction in Madhya Pradesh. The final draft of Women's Policy 2013-2017, submitted to the state government for a formal nod, protects legal rights of live-in partners. Coming as it does just months before the state goes to polls, the draft policy provides for free legal aid for rape victims apart from offering sops to women like two years of...
More »In the ‘pharmacy of the world’ -PT Jyothi Datta
-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...
More »
